Efficacy of Alfuzosin in Male Patients with Moderate Lower Urinary Tract Symptoms: Is Metabolic Syndrome a Factor Affecting the Outcome?


SÖNMEZ G. , Topaloglu U. S. , Keske M., DEMİRTAŞ A.

UROLOGY JOURNAL, cilt.17, ss.517-521, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 17 Konu: 5
  • Basım Tarihi: 2020
  • Doi Numarası: 10.22037/uj.v16i7.6204
  • Dergi Adı: UROLOGY JOURNAL
  • Sayfa Sayıları: ss.517-521

Özet

Purpose: The present study was designed to compare the efficacy of alfuzosin therapy as an alpha-blocker in metabolic syndrome (MetS) and non-MetS patients with moderate lower urinary tract symptoms (LUTS).